Avaleht › Dermatomüosiit › New York
Dermatomüosiit kliinilised uuringud osariigis New York
6 uuringut haiguse Dermatomüosiit jaoks otsivad osalejaid osariigis New York.
Linnad osariigis New York
Ametlik uuringutekst (inglise keeles)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Great Neck
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 24. sept 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- ja veel 1
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
- Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
- Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients, The Bronx
VärbamineFaas 2/3
Vanused 6–75 · Kõik sood · Uuendatud 17. sept 2026 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- NYU Langone Health - Clinical and Translational Science Institute Research Pharmacy, New York
- NYU Langone Health Clinical Research Center, New York
- NYU Langone Health, New York
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 15. sept 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Icahn School of Medicine at Mount Sinai, New York
VärbamineFaas 1
Vanused 18–74 · Kõik sood · Uuendatud 10. sept 2026 · NCT07085104Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. juuli 2026 · NCT07138898Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.